ZSAN Zosano Pharma Corp

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2015
Outstanding shares:  118,346,993
Average volume:  4,943,627
Market cap:   $71,008,196
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98979H202
ISIN:        US98979H2022
Valuation   (See tab for details)
PE ratio:   -3.04
PB ratio:   1.83
PS ratio:   101.73
Return on equity:   -60.08%
Net income %:   -3,288.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy